Considering the interaction between body fat mass and insulin resistance, our results suggest that under our HFHS diet, the increased insulin sensitivity in response to olanzapine is in part the result of olanzapine-induced reduction in fat mass and weight gain, a condition which could not have been obtained in the acute treatment mentioned above. This evidence concerns the gene INS and Insulin resistance.